Mengis Capital Management’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.84M Sell
6,705
-75
-1% -$15.8K 0.27% 86
2026
Q2
$1.19M Sell
6,780
-30
-0.4% -$4.39K 0.18% 111
2026
Q1
$839K Sell
6,810
-2,155
-24% -$283K 0.14% 125
2025
Q4
$1.18M Sell
8,965
-75
-0.8% -$8.8K 0.21% 102
2025
Q3
$859K Buy
9,040
+20
+0.2% +$1.98K 0.17% 112
2025
Q2
$861K Sell
9,020
-422
-4% -$34.2K 0.18% 108
2025
Q1
$749K Hold
9,442
– – 0.16% 117
2024
Q4
$1.26M Buy
9,442
+80
+0.9% +$11.4K 0.26% 90
2024
Q3
$1.22M Buy
+9,362
New +$1.15M 0.24% 93

Other funds holding ILMN

Mengis Capital Management's ILMN Position: Q3 2026 in Review

Mengis Capital Management reduced its Illumina (ILMN) stake by 1.1% in Q3 2026, selling an estimated $15.8K and leaving 6,705 shares worth $1.84M. The position accounts for 0.27% of the portfolio, ranked #86.

Mengis Capital Management first reported a position in ILMN in Q3 2024 and has held it in 9 quarters since. 799 funds tracked by Wall St. Rank hold ILMN as of Q3 2026.

  • Mengis Capital Management held 6,705 shares of Illumina worth $1.84M as of Q3 2026.
  • Mengis Capital Management sold 75 Illumina shares in Q3 2026, an estimated $15.8K.
  • Illumina made up 0.27% of Mengis Capital Management's portfolio in Q3 2026, its #86 holding.
  • Mengis Capital Management first reported a position in Illumina in Q3 2024 and has held it in 9 quarters since.
  • 799 funds tracked by Wall St. Rank held Illumina as of Q3 2026.

Based on Mengis Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.